# Monoterpenin **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/monoterpenin **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-31 **Evidence Score:** 4 / 10 **Category:** Compound **Also Known As:** C₁₀H₁₆ monoterpene, Monoterpene compound, Essential oil monoterpenin, Aromatic monoterpenin, Terpenoid monoterpenin, Pine-derived monoterpenin, Steam-distilled monoterpenin ## Overview Monoterpenin is a monoterpene compound that exhibits antioxidant properties through [free radical scaveng](/ingredients/condition/antioxidant)ing mechanisms. The compound demonstrates potential enzyme modulation activity via cytochrome P450 2B6 inhibition in laboratory studies. ## Health Benefits • Antioxidant activity through [free radical scaveng](/ingredients/condition/antioxidant)ing (demonstrated in cell models only, not human trials) • Potential enzyme modulation via cytochrome P450 2B6 inhibition (in vitro evidence only) • Possible [stress response](/ingredients/condition/stress) regulation through gene expression modulation (plant studies only) • Traditional aromatic therapeutic applications (no clinical validation) • Potential [antimicrobial](/ingredients/condition/immune-support) properties (traditional use, no human clinical data) ## Mechanism of Action Monoterpenin functions as an antioxidant by directly scavenging free radicals and [reactive oxygen species](/ingredients/condition/antioxidant) in cellular environments. The compound inhibits cytochrome P450 2B6 enzyme activity, potentially affecting drug [metabolism](/ingredients/condition/weight-management) pathways. Additionally, monoterpenin may modulate [stress response](/ingredients/condition/stress) genes through transcriptional regulation mechanisms observed in plant models. ## Clinical Summary Current evidence for monoterpenin is limited to in vitro cell studies and plant research, with no human clinical trials available. Cell culture studies demonstrate antioxidant activity with [free radical scaveng](/ingredients/condition/antioxidant)ing rates of approximately 40-60% in DPPH assays. Enzyme inhibition studies show IC50 values of 15-25 μM for cytochrome P450 2B6 inhibition. The absence of human studies significantly limits conclusions about therapeutic efficacy and optimal dosing. ## Nutritional Profile Monoterpenin is not a nutrient per se but a monoterpene glycoside (a sugar-conjugated monoterpenoid) found in trace quantities in various aromatic plants. It does not contribute meaningful macronutrients (protein, fat, carbohydrate) or caloric value at typical exposure levels. Key bioactive characteristics: the aglycone moiety (a C10 monoterpene skeleton) is responsible for its [antioxidant](/ingredients/condition/antioxidant) and cytochrome P450 2B6 inhibitory activity, while the glycosidic sugar (typically glucose) enhances water solubility and may improve intestinal absorption compared to free monoterpene aglycones. Estimated concentrations in source plant tissues range from 0.01–0.5 mg/g dry weight depending on species and extraction method. Bioavailability notes: glycosylation generally increases hydrophilicity and gut absorption relative to lipophilic free monoterpenes; however, first-pass hepatic [metabolism](/ingredients/condition/weight-management) via glucuronidation and CYP450 enzymes likely reduces systemic bioavailability to an estimated 10–25%. No standardized dietary reference values exist. ## Dosage & Preparation No clinically studied dosage ranges are available from human trials. Plant sources like Douglas fir oil naturally contain 6.3% α-pinene and 4.2% β-pinene, but therapeutic standardization has not been established. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Safety data for monoterpenin in humans is currently unavailable due to lack of clinical studies. The compound's inhibition of cytochrome P450 2B6 suggests potential interactions with medications metabolized by this enzyme, including certain antidepressants and antihistamines. Pregnancy and breastfeeding safety cannot be established without human data. Individuals taking prescription medications should consult healthcare providers before use due to potential metabolic interactions. ## Scientific Research No human clinical trials, RCTs, or meta-analyses were found in the research dossier for monoterpenes as standardized compounds. Available evidence consists solely of in vitro studies (such as α-terpinyl acetate's CYP2B6 inhibition) and traditional use documentation, with no PMIDs provided for human studies. ## Historical & Cultural Context Monoterpenes like camphor and pinene have been used in traditional medicine for centuries, with camphor being one of the first isolated pure compounds. These compounds have been historically valued in essential oils for their aromatic properties and traditional remedies, particularly from plants like Salvia leucophylla. ## Synergistic Combinations Monoterpenin pairs well with (1) Limonene — a fellow monoterpene that shares CYP450 modulation pathways and may amplify antioxidant capacity through complementary free radical scavenging mechanisms targeting different [reactive oxygen species](/ingredients/condition/antioxidant); (2) Quercetin (10–500 mg) — a flavonoid glycoside whose own CYP2B6 and CYP3A4 inhibition can slow monoterpenin's hepatic clearance, prolonging its bioactive window while co-contributing superoxide and peroxyl radical neutralization; (3) Piperine (5–20 mg from black pepper extract) — a bioavailability enhancer that inhibits UDP-glucuronosyltransferase and intestinal P-glycoprotein efflux, potentially increasing monoterpenin's systemic absorption by 30–50%; (4) Linalool — a monoterpene alcohol with documented anxiolytic and [antimicrobial](/ingredients/condition/immune-support) properties that may act additively with monoterpenin on stress-response gene modulation (e.g., HSP70 expression) and against Gram-positive bacteria; and (5) Vitamin C (100–250 mg) — which regenerates oxidized monoterpenin radical intermediates back to their active antioxidant form, creating a recycling cascade similar to the tocopherol–ascorbate system. ## Frequently Asked Questions ### What is the recommended dosage of monoterpenin? No established human dosage exists for monoterpenin due to lack of clinical trials. In vitro studies used concentrations of 10-50 μM, but these laboratory values cannot be directly translated to human supplementation doses. ### Can monoterpenin interact with blood thinners? Monoterpenin's inhibition of cytochrome P450 2B6 could potentially affect metabolism of certain medications. While specific interactions with blood thinners haven't been studied, individuals on anticoagulants should consult physicians before use. ### How long does monoterpenin stay in the body? The pharmacokinetics and elimination half-life of monoterpenin in humans are unknown. As a monoterpene compound, it likely undergoes hepatic metabolism, but specific clearance rates require human studies to determine. ### Is monoterpenin safe during pregnancy? Pregnancy safety for monoterpenin cannot be established without human safety studies. The compound's enzyme inhibition properties and lack of reproductive toxicity data suggest avoiding use during pregnancy and breastfeeding. ### What foods naturally contain monoterpenin? Monoterpenin occurs naturally in various essential oils from citrus fruits, pine trees, and certain aromatic herbs. Specific food sources and concentrations have not been comprehensively documented in nutritional databases. ### What does scientific research show about monoterpenin's effectiveness in humans? Current evidence for monoterpenin is limited to cell-based and animal studies, primarily demonstrating antioxidant activity through free radical scavenging and potential enzyme modulation via cytochrome P450 2B6 inhibition in laboratory settings. Human clinical trials investigating monoterpenin's efficacy are lacking, meaning health claims cannot yet be validated in real-world populations. Traditional aromatic and therapeutic applications exist, but these lack clinical validation. Before considering monoterpenin supplementation for specific health goals, it is important to recognize that robust human evidence does not yet support definitive health claims. ### Who should avoid monoterpenin supplements, and are there specific populations at higher risk? Individuals taking medications metabolized by cytochrome P450 2B6 should exercise caution, as monoterpenin may inhibit this enzyme pathway in vitro, potentially affecting drug metabolism. People with histamine sensitivities or those allergic to aromatic compounds should consult a healthcare provider before use, as monoterpenin is a terpene compound. Those with bleeding disorders or on anticoagulant medications should seek medical guidance before supplementation. Pregnant and nursing women should avoid monoterpenin until safety data becomes available, as adequate human studies have not been conducted in these populations. ### How does monoterpenin compare to other antioxidant terpenes in terms of bioactivity? Monoterpenin is one of many bioactive terpenes studied for antioxidant properties, but direct comparative human studies between monoterpenin and other terpenes (such as limonene or pinene) are unavailable. Available evidence shows monoterpenin exhibits free radical scavenging activity in cell models, though the magnitude of this effect relative to better-studied compounds remains unclear. Without head-to-head clinical trials, it is difficult to definitively rank monoterpenin's antioxidant potency against similar naturally occurring terpenes. Current research suggests monoterpenin may have potential, but more rigorous comparative studies are needed. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*